TANG CAPITAL MANAGEMENT LLC - Dec 31, 2024 SCHEDULE 13G/A Report for ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share (ITOS)

Reporting Managers (5)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TANG CAPITAL MANAGEMENT, LLC	0.6%	222K	222K	/s/ Kevin Tang	Manager
KEVIN TANG	0.6%	222K	222K	/s/ Kevin Tang	Self
TANG CAPITAL PARTNERS, LP	0.6%	222K	222K	/s/ Kevin Tang	Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC	0%	0	0	/s/ Kevin Tang	Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC	0%	0	0	/s/ Kevin Tang	Chief Executive Officer

Showing 1 to 5 of 5 entries